These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cycas micronesica (Cycadales) plants devoid of endophytic cyanobacteria increase in beta-methylamino-L-alanine. Marler TE; Snyder LR; Shaw CA Toxicon; 2010 Sep; 56(4):563-8. PubMed ID: 20570592 [TBL] [Abstract][Full Text] [Related]
3. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Bradley WG; Mash DC Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726 [TBL] [Abstract][Full Text] [Related]
4. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans. Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725 [TBL] [Abstract][Full Text] [Related]
6. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Cox PA; Banack SA; Murch SJ Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559 [TBL] [Abstract][Full Text] [Related]
7. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Ince PG; Codd GA Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818 [TBL] [Abstract][Full Text] [Related]
8. Quantification of the putative neurotoxin 2-amino-3-(methylamino)propanoic acid (BMAA) in cycadales: analysis of the seeds of some members of the family Cycadaceae. Duncan MW; Kopin IJ; Crowley JS; Jones SM; Markey SP J Anal Toxicol; 1989; 13(4):suppl A-G. PubMed ID: 2490746 [TBL] [Abstract][Full Text] [Related]
9. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Duncan MW; Steele JC; Kopin IJ; Markey SP Neurology; 1990 May; 40(5):767-72. PubMed ID: 2330104 [TBL] [Abstract][Full Text] [Related]
10. Presence of ß-N-methylamino-L-alanine in cyanobacteria and aquatic organisms from waters of Northern Poland; BMAA toxicity studies. Błaszczyk A; Siedlecka-Kroplewska K; Woźniak M; Mazur-Marzec H Toxicon; 2021 Apr; 194():90-97. PubMed ID: 33610631 [TBL] [Abstract][Full Text] [Related]
11. Animal models of BMAA neurotoxicity: a critical review. Karamyan VT; Speth RC Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417 [TBL] [Abstract][Full Text] [Related]
12. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis. Banack SA; Caller TA; Stommel EW Toxins (Basel); 2010 Dec; 2(12):2837-50. PubMed ID: 22069578 [TBL] [Abstract][Full Text] [Related]
13. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Banack SA; Cox PA Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204 [TBL] [Abstract][Full Text] [Related]
18. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis. Stommel EW; Field NC; Caller TA Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360 [TBL] [Abstract][Full Text] [Related]
19. Production of the neurotoxin BMAA by a marine cyanobacterium. Banack SA; Johnson HE; Cheng R; Cox PA Mar Drugs; 2007 Dec; 5(4):180-96. PubMed ID: 18463731 [TBL] [Abstract][Full Text] [Related]